Adam Testro

2.2k total citations
113 papers, 1.3k citations indexed

About

Adam Testro is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Adam Testro has authored 113 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hepatology, 51 papers in Epidemiology and 44 papers in Surgery. Recurrent topics in Adam Testro's work include Liver Disease and Transplantation (52 papers), Liver Disease Diagnosis and Treatment (37 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Adam Testro is often cited by papers focused on Liver Disease and Transplantation (52 papers), Liver Disease Diagnosis and Treatment (37 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Adam Testro collaborates with scholars based in Australia, United States and New Zealand. Adam Testro's co-authors include Paul Gow, Peter Angus, Kumar Visvanathan, Marie Sinclair, Brooke Chapman, John Lubel, A. Koshy, Rudolf Hoermann, Robert Jones and Omar Farouque and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Adam Testro

99 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Adam Testro 531 526 402 252 160 113 1.3k
Florence Lacaille 431 0.8× 289 0.5× 422 1.0× 81 0.3× 295 1.8× 63 1.3k
Girish Gupte 509 1.0× 411 0.8× 736 1.8× 142 0.6× 598 3.7× 109 2.0k
Niamh Nolan 673 1.3× 588 1.1× 374 0.9× 149 0.6× 34 0.2× 64 1.8k
Ayano Inui 1.1k 2.0× 977 1.9× 423 1.1× 126 0.5× 194 1.2× 163 2.0k
Siyuan Yao 287 0.5× 292 0.6× 490 1.2× 525 2.1× 135 0.8× 81 1.4k
W D Reed 787 1.5× 694 1.3× 1.0k 2.5× 69 0.3× 140 0.9× 68 2.4k
Nada Yazigi 184 0.3× 400 0.8× 602 1.5× 44 0.2× 181 1.1× 58 1.2k
Tomoo Fujisawa 1.1k 2.1× 1.0k 2.0× 564 1.4× 72 0.3× 173 1.1× 158 2.0k
Christoph Jochum 827 1.6× 725 1.4× 412 1.0× 70 0.3× 37 0.2× 68 1.5k
Fernando Casafont 1.4k 2.6× 1.2k 2.2× 635 1.6× 150 0.6× 28 0.2× 72 2.1k

Countries citing papers authored by Adam Testro

Since Specialization
Citations

This map shows the geographic impact of Adam Testro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Testro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Testro more than expected).

Fields of papers citing papers by Adam Testro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Testro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Testro. The network helps show where Adam Testro may publish in the future.

Co-authorship network of co-authors of Adam Testro

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Testro. A scholar is included among the top collaborators of Adam Testro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Testro. Adam Testro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Testro, Adam, et al.. (2025). The current applications and future directions of terlipressin. Hepatology Communications. 9(4). 1 indexed citations
2.
Urbancic, Karen, Gemma Reynolds, Sara Vogrin, et al.. (2025). Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program. Transplant Infectious Disease. 27(4). e70046–e70046.
3.
Cailes, B., E. Huber, Omar Farouque, et al.. (2025). Blunted cardiac reserve as a marker of cirrhotic cardiomyopathy—Cardiac outcomes following liver transplantation and comparison to the existing guidelines. American Journal of Transplantation. 25(9). 1976–1986. 1 indexed citations
4.
Cailes, B., Numan Kutaiba, Omar Farouque, et al.. (2025). Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients. Liver Transplantation. 31(12). 1522–1532.
5.
Chapman, Brooke, et al.. (2025). Real-World Experience of Home Continuous Terlipressin Infusion for Complications of Portal Hypertension. The American Journal of Gastroenterology.
6.
Kutaiba, Numan, Himashi Peiris, Stefan R. Kachel, et al.. (2025). Impact of local data from patients with chronic liver disease on accuracy of a liver and spleen CT segmentation model trained on a public dataset. Monash University Research Portal (Monash University). 3. 100023–100023. 1 indexed citations
7.
Hoermann, Rudolf, Marie Sinclair, Brooke Chapman, et al.. (2024). Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial. Alimentary Pharmacology & Therapeutics. 59(8). 941–952. 10 indexed citations
8.
Cailes, B., A. Koshy, Avik Majumdar, et al.. (2024). Impaired Cardiac Reserve is a Novel Predictor of Major Adverse Cardiovascular Events After Liver Transplantation. Heart Lung and Circulation. 33. S127–S128.
9.
Kutaiba, Numan, et al.. (2023). Deep Learning for Computed Tomography Assessment of Hepatic Fibrosis and Cirrhosis: A Systematic Review. SHILAP Revista de lepidopterología. 1(4). 574–585. 5 indexed citations
11.
12.
Lee, Eunice, Michael Fink, Graham Starkey, et al.. (2023). A Single Centre Experience with Pre-Operative Markers in the Prediction of Outcomes after Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 27(7). 1376–1386. 2 indexed citations
14.
Chapman, Brooke, Darren Wong, Marie Sinclair, et al.. (2023). Redefining Nutritional Requirements in End-Stage Liver Disease: Towards a Personalized Approach. Nutrients. 15(22). 4770–4770. 1 indexed citations
15.
Chapman, Brooke, Su Kah Goh, Frank Parker, et al.. (2022). Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant. Clinical Nutrition ESPEN. 48. 210–219. 22 indexed citations
17.
Koshy, A., A. Teh, Paul Gow, et al.. (2020). POST-OPERATIVE ATRIAL FIBRILLATION FOLLOWING LIVER TRANSPLANTATION AND ASSOCIATION WITH ADVERSE CARDIOVASCULAR EVENTS. Journal of the American College of Cardiology. 75(11). 198–198. 1 indexed citations
18.
Koshy, A., Paul Gow, B. Cailes, et al.. (2020). BETA-BLOCKER USE IS ASSOCIATED WITH AN INCREASED EARLY RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ORTHOTOPIC LIVER TRANSPLANTATION. Journal of the American College of Cardiology. 75(11). 1942–1942. 1 indexed citations
19.
Sinclair, Marie, et al.. (2019). Handgrip strength adds more prognostic value to the MELD score than imaging-based measures of muscle mass in men awaiting liver transplantation. Journal of Hepatology. 70(1). 1 indexed citations
20.
Smith, Rebecca L., Douglas Johnson, Patrick G. P. Charles, et al.. (2016). Endoscopic investigation in non-iron deficiency anemia: a cost to the health system without patient benefit. SHILAP Revista de lepidopterología. 4(2). E198–E201. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026